Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia

Elizabeth DiMaggio, Jun Min Zhou, Ryan Caddell, Rebecca Tombleson, Janelle Perkins, Claudio Anasetti, Farhad Khimani, Joseph Pidala, Taiga Nishihori, Lia Perez, Brian Betts, Hugo F. Fernandez, Asmita Mishra

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences